Last reviewed · How we verify
NCT03528486
Interventions to Attenuate Cognitive Decline: Keys to Staying Sharp
NA trial testing Music Training I in Mild Cognitive Impairment in 268 participants. Completed in 30 December 2021.
30 August 2021
Quick facts
| Lead sponsor | University of South Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | prevention |
| Enrollment | 268 |
| Start date | 29 January 2018 |
| Primary completion | 30 August 2021 |
| Estimated completion | 30 December 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Music Training I
Conditions studied
- Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →
- Age-related Cognitive Decline — all drugs for Age-related Cognitive Decline →
Sponsor
University of South Florida
Who can join
60 and older, any sex, with Mild Cognitive Impairment or Age-related Cognitive Decline. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Different cognitive intervention approaches have been developed to attenuate decline (e.g., cognitive engagement, training, or stimulation), but it is not clear which approaches are efficacious. It is also not clear when, along the continuum of normal cognitive aging to mild cognitive impairment (MCI-a transitional stage before dementia onset), it is most efficacious to intervene. This randomized clinical trial will determine the efficacy of a novel cognitive engagement intervention approach (music training) as compared to cognitive stimulation (which will serve as a stringent, active control). Grounded in theory, the central hypothesis is that interventions enhancing central auditory processing (CAP), a strong, longitudinal predictor of MCI and dementia, will improve cognition. Music training is increasingly recognized as a feasible means to attenuate age-related cognitive decline. Prior research and preliminary data suggest that intense piano training enhances CAP and is likely more effective than cognitive stimulation. Correlational studies indicate superior CAP, executive function, and other cognitive abilities for adults with formal music training compared to non-musicians. The specific aims of the study are to examine the efficacy of music training relative to cognitive stimulation (active controls) to improve CAP, cognition, and everyday function among older adults with and without MCI. The efficacy of music training will be established and moderating effects of MCI status will be examined. The proposed study further aims to elucidate the underlying mechanisms of effective cognitive intervention approaches by exploring mediators of training gains. The proposed study is the first phase II randomized trial of music training to enhance older adults' cognition. Mediation analyses will elucidate the underlying mechanisms of intervention effects.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Keys to staying sharp: A randomized clinical trial of piano training among older adults with and without mild cognitive impairment.
Hudak EM, Bugos J, Andel R, Lister JJ, et al · · 2019 · cited 5× · PMID 31226405 · DOI 10.1016/j.cct.2019.06.003 -
The Effects of Piano Training on Auditory Processing, Cognition, and Everyday Function.
Lister JJ, Hudak EM, Andel R, Edwards JD. · · 2023 · cited 2× · PMID 41585426 · DOI 10.1007/s41465-023-00256-z -
Auditory Processing but Not Peripheral Hearing Differs Between Older Adults With and Without Mild Cognitive Impairment.
Lister JJ, Carmenate-Nichols R, Hudak EM, O'Brien JL, et al · · 2024 · cited 1× · PMID 38787303 · DOI 10.1044/2024_aja-23-00166 -
The influence of peer navigators on intervention adherence and retention among older adults: A study within a randomized trial - SWAT.
Runge SK, Hudak EM, Sutfin JA, Dobrovolskiy VR, et al · · 2026 · PMID 41453521 · DOI 10.1016/j.cct.2025.108206
Verify or expand the search:
- PubMed search for NCT03528486
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Mild Cognitive Impairment
Currently open trials in the same condition.
- NCT05791994 — EVASION: Effect of VisuAl Stimulation on attentION · NA · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07220694 — Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairmen · NA · recruiting
- NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
- NCT07318038 — The Use of Rhythmic Light Therapy in Mild Cognitive Impairment · NA · recruiting
Other University of South Florida trials
Trials by the same sponsor.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07342569 — The WeACT Program for Family Caregivers of People Living With Dementia · NA · not yet recruiting
- NCT07502378 — Effect of Acoltremon Ophthalmic Solution 0.003% on Signs and Symptoms of Ocular Surface Disease in Stage I Neurotrophic · Phase 4 · recruiting
- NCT07241260 — Hydrate Heroes for Improving Brain Function & Mood · NA · not yet recruiting
- NCT06377215 — Understanding Aided Speech Perception in Noise · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03528486 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Florida
- Last refreshed: 21 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03528486.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing